These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35955717)

  • 1. Consequences of Acute or Chronic Methylphenidate Exposure Using Ex Vivo Neurochemistry and In Vivo Electrophysiology in the Prefrontal Cortex and Striatum of Rats.
    Di Miceli M; Derf A; Gronier B
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Administration of Methylphenidate (Ritalin) Affects Dopamine Release Differentially Between the Prefrontal Cortex and Striatum: A Microdialysis Study in the Monkey.
    Kodama T; Kojima T; Honda Y; Hosokawa T; Tsutsui KI; Watanabe M
    J Neurosci; 2017 Mar; 37(9):2387-2394. PubMed ID: 28154152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic methylphenidate preferentially alters catecholamine protein targets in the parietal cortex and ventral striatum.
    Quansah E; Zetterström TSC
    Neurochem Int; 2019 Mar; 124():193-199. PubMed ID: 30660754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.
    Somkuwar SS; Kantak KM; Dwoskin LP
    J Neurosci Methods; 2015 Aug; 252():55-63. PubMed ID: 25680322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury.
    Wagner AK; Drewencki LL; Chen X; Santos FR; Khan AS; Harun R; Torres GE; Michael AC; Dixon CE
    J Neurochem; 2009 Feb; 108(4):986-97. PubMed ID: 19077052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors.
    Di Miceli M; Gronier B
    Psychopharmacology (Berl); 2015 Jun; 232(12):2191-205. PubMed ID: 25572531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate increases cortical excitability via activation of alpha-2 noradrenergic receptors.
    Andrews GD; Lavin A
    Neuropsychopharmacology; 2006 Mar; 31(3):594-601. PubMed ID: 15999146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness.
    Devilbiss DM; Berridge CW
    Biol Psychiatry; 2008 Oct; 64(7):626-35. PubMed ID: 18585681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroPET/CT assessment of neurochemical effects in the brain after long-term methylphenidate treatment in nonhuman primates.
    Zhang X; Talpos J; Berridge MS; Apana SM; Slikker W; Wang C; Paule MG
    Neurotoxicol Teratol; 2021; 87():107017. PubMed ID: 34265415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Methylphenidate on the Dopamine Transporter and Beyond.
    Zetterström TSC; Quansah E; Grootveld M
    Curr Top Behav Neurosci; 2022; 57():127-157. PubMed ID: 35507284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate administration reverts attentional inflexibility in adolescent rats submitted to a model of neonatal hypoxia-ischemia: Predictive validity for ADHD study.
    Miguel PM; Deniz BF; Confortim HD; Bronauth LP; de Oliveira BC; Alves MB; Silveira PP; Pereira LO
    Exp Neurol; 2019 May; 315():88-99. PubMed ID: 30771298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
    Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of methylphenidate after long-term exposure in nonhuman primates.
    Zhang X; Berridge MS; Apana SM; Slikker W; Paule MG; Talpos J
    Neurotoxicol Teratol; 2023; 97():107173. PubMed ID: 36893929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of environmental enrichment on methylphenidate-induced locomotion and dopamine transporter dynamics.
    Wooters TE; Bardo MT; Dwoskin LP; Midde NM; Gomez AM; Mactutus CF; Booze RM; Zhu J
    Behav Brain Res; 2011 May; 219(1):98-107. PubMed ID: 21219939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action.
    Zhang CL; Feng ZJ; Liu Y; Ji XH; Peng JY; Zhang XH; Zhen XC; Li BM
    PLoS One; 2012; 7(12):e51910. PubMed ID: 23284812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of methylphenidate on c-Fos expression in parvalbumin interneurons of juvenile rat frontal cortex].
    Zhang YC; Zhu XQ; Zhang XH
    Sheng Li Xue Bao; 2017 Aug; 69(4):378-384. PubMed ID: 28825095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice.
    Sadasivan S; Pond BB; Pani AK; Qu C; Jiao Y; Smeyne RJ
    PLoS One; 2012; 7(3):e33693. PubMed ID: 22470460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: involvement of dopamine D1 and alpha 2 adrenergic receptors.
    Gronier B
    Eur Neuropsychopharmacol; 2011 Feb; 21(2):192-204. PubMed ID: 21146374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Towards an understanding of the molecular mechanisms underlying the pharmacological treatments of attention deficit hyperactivity disorder].
    Castellanos FX; Acosta MT
    Rev Neurol; 2011 Mar; 52 Suppl 1():S155-60. PubMed ID: 21365598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of methylphenidate-induced excitation in midbrain dopamine neurons, an electrophysiological study in the rat brain.
    Di Miceli M; Omoloye A; Gronier B
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jan; 112():110406. PubMed ID: 34339759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.